AnxietyNCT06185309
Evaluation of Different Psychiatric Symptoms in Patients With Thyroid Dysfunction
An observational study of Anxiety and Depression, run by Assiut University.
Trial summary
1. Evaluate psychiatric symptoms in patients with thyroid dysfunction. 2. Investigate effect of treatment on psychiatric symptoms after 2 months. Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Anxiety, Depression, Thyroid Dysfunction
- How many people
- 85 participants
- Where
- No sites listed yet
- Study dates
- 1 Jan 2024to 1 Feb 2025
- How long will I take part?
- 2 Months
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: Patients newly diagnosed as having thyroid dysfunction.
Who may be able to join
- Patients newly diagnosed as having thyroid dysfunction.
Who cannot join
- Patients with other endocrinological disorders or significant medical or neurological diseases.
- Alcohol or substance abuse
Trial locations and contacts
No sites are listed yet.
About this study
Official title: Assessment of Different Psychiatric Symptoms in Patients With Thyroid Dysfunction: Pre and Post Thyroid Treatment
- Evaluate psychiatric symptoms in patients with thyroid dysfunction.
- Investigate effect of treatment on psychiatric symptoms after 2 months.
Read the detailed description
Thyroid dysfunction is associated with psychiatric symptoms in addition to endocrinal manifestations.
The study aims to evaluate the prevalence of psychiatric symptoms in patients with thyroid dysfunction and investigate the response after thyroid treatment.
- Conditions
- Anxiety, Depression, Thyroid Dysfunction
- Medical subject headings
- Anxiety Disorders, Depression
What is being measured
The primary outcome is the main question the study is designed to answer.
The effect of thyroid treatment on psychiatric symptoms
Investigate the effect of thyroid treatment on psychiatric symptoms associated with thyroid dysfunction.
Measured: 2 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted29 Dec 2023
- Study start1 Jan 2024 (estimated)
- Primary completion1 Jan 2025 (estimated)
- Study completion1 Feb 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (2)Papers the sponsor has linked to this study.
- Other trials for AnxietyStudies of the same condition, open and under way.
- More trials run by Assiut UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 85 participants (estimated)
- Target duration
- 2 Months
Sponsor and investigators
- Lead sponsor
- Assiut University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Ahmed EmadElden Mohamed, Assiut University
- Investigators
- Romany Hosny Gabra Henein, professor, Study director, Assiut UniversityKhaled Ahmed Mohamed, Professor, Study director, Assiut University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06185309
- Sponsor's protocol ID
- Psychiatry & thryoid disorders
- Status last verified
- Dec 2023
- First submitted
- 5 Dec 2023
- Last updated
- 29 Dec 2023
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Publications
Aslan S, Ersoy R, Kuruoglu AC, Karakoc A, Cakir N. Psychiatric symptoms and diagnoses in thyroid disorders: a cross-sectional study. Int J Psychiatry Clin Pract. 2005;9(3):187-92. doi: 10.1080/13651500510029129.
PubMed 24937789Gulseren S, Gulseren L, Hekimsoy Z, Cetinay P, Ozen C, Tokatlioglu B. Depression, anxiety, health-related quality of life, and disability in patients with overt and subclinical thyroid dysfunction. Arch Med Res. 2006 Jan;37(1):133-9. doi: 10.1016/j.arcmed.2005.05.008.
PubMed 16314199
Study at a glance
From the registry record, last updated by the sponsor on 29 Dec 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Assessment of Different Psychiatric Symptoms in Patients With Thyroid Dysfunction: Pre and Post Thyroid Treatment
- ClinicalTrials.gov ID
- NCT06185309
- Acronym / sponsor ID
- Psychiatry & thryoid disorders
- Conditions
- Anxiety, Depression, Thyroid Dysfunction
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 85 participants (estimated)
- Lead sponsor
- Assiut UniversityUniversity, hospital or other
- Study start
- 1 Jan 2024 (estimated)
- Primary completion
- 1 Jan 2025 (estimated)
- Study completion
- 1 Feb 2025 (estimated)
- First posted
- 29 Dec 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
- Evaluate psychiatric symptoms in patients with thyroid dysfunction.
- Investigate effect of treatment on psychiatric symptoms after 2 months.
Detailed description
Thyroid dysfunction is associated with psychiatric symptoms in addition to endocrinal manifestations.
The study aims to evaluate the prevalence of psychiatric symptoms in patients with thyroid dysfunction and investigate the response after thyroid treatment.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Target follow-up
- 2 Months
Who may qualify
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
- Study population
- Patients newly diagnosed as having thyroid dysfunction.
Key inclusion criteria (1 listed)
- Patients newly diagnosed as having thyroid dysfunction.
Key exclusion criteria (2 listed)
- Patients with other endocrinological disorders or significant medical or neurological diseases.
- Alcohol or substance abuse
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
The effect of thyroid treatment on psychiatric symptoms
Time frame: 2 months
Investigate the effect of thyroid treatment on psychiatric symptoms associated with thyroid dysfunction.
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 29 Dec 2023.
- Results publication: PubMed 24937789Aslan S, Ersoy R, Kuruoglu AC, Karakoc A, Cakir N. Psychiatric symptoms and diagnoses in thyroid disorders: a cross-sectional study. Int J Psychiatry Clin Pract. 2005;9(3):187-92. doi: 10.1080/13651500510029129.
- Results publication: PubMed 16314199Gulseren S, Gulseren L, Hekimsoy Z, Cetinay P, Ozen C, Tokatlioglu B. Depression, anxiety, health-related quality of life, and disability in patients with overt and subclinical thyroid dysfunction. Arch Med Res. 2006 Jan;37(1):133-9. doi: 10.1016/j.arcmed.2005.05.008.
- Prevalence, risks, and comorbidity of thyroid dysfunction: a cross-sectional epidemiological studyLink provided by the sponsor.
Related trials for Anxiety
Not yet recruiting
Building Resilience Through Anxiety Virtual Education in PICU Survivors
Critical Illness Recovery, Mental Health
Not yet recruiting
Mandala Coloring in Late Pregnancy
Pregnancy, Anxiety
Recruiting
Modulating Escape Using Focused Ultrasound
Anxiety Disorders
Not yet recruitingObservational study
Ecological Momentary Assessment of State-Dependent Decision-Making and Metacognition Across a Psychopathology Continuum
Depression, Anxiety
Recruiting
Stress and Anxiety Effects on Valuation
Reward Value Level
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Romany Hosny Gabra Henein, professor study director
Assiut University
Khaled Ahmed Mohamed, Professor study director
Assiut University
Questions about this trial
What is this clinical trial studying?
An observational study of Anxiety and Depression, run by Assiut University.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 29 Dec 2023. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Ahmed EamdElden Mohamed Abdelhafez, MBCCH (+201000316881, ahmed.15235502@med.aun.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
The effect of thyroid treatment on psychiatric symptoms (time frame: 2 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06185309, which also lists 2 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Dec 2023.